Market Place
Filter By Unselect All
Sub Category Unselect See All
Country Unselect See All
Companies Unselect See All
AMRI (1)
Anacipher (1)
Crystec Pharma (1)
Dalton Pharma (1)
GVK Biosciences (1)
Merck Millipore (1)
PCI Synthesis (1)
PharmaVize NV (1)
Pierre Fabre (1)
Ropack Inc (1)
UQUIFA (1)
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
Cocrystal Screening 
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
Comprehensive cocrystal screen and ongoing support for selection
Website
Polymorph & Crystal Screening
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
Quotient Sciences’ experienced material scientists can support your pre-formulation screening to allow selection of your drug candidate for preclinical evaluation and identification of your drug product in early clinical evaluation.
Polymorph Development
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
Biophore, an established pharmaceutical company, is engaged in the development and manufacturing of niche pharmaceutical products for the generic industry. Biophore has emerged as a trusted partner in the generic industry across US, Europe and other regulated markets.
Polymorphism Studies
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
Uquifa offers the opportunity to manage the development activities of any drug life cycle by offering services on DMF/CTD/COS application, stability studies, process validation and analytical method validation, working standard supply or impurity
Formuldisp®
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
It is a one step process using supercritical CO2 as a solvent to incorporate an API in an excipient matrix. Process without organic solvent, it allows to obtain a complete and stable amorphization at low temperature and without mechanical stress.
Polymorph Screening
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
The comprehensive examination of the range of polymorphs which can be prepared for specific drug compounds is of profound importance for pharmaceutical companies. There are major implications in discovering all potential forms for both commercial and regulatory reasons.
Polymorphic Evaluation/Polymorph Quantification by XRD
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
Determination of physic-chemical properties as follows: Solubility with respect to temperature and pH, dissociation constant and partition coefficient, polymorphic evaluation and hygroscopicty.
Polymorph Screening & Selection
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
Our dedicated team of scientists have their core training in the area of preformulation and have expertise in the complete pharmaceutical profiling of molecules.
Crystalline Properties
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
Our dedicated team of scientists have their core training in the area of preformulation and have expertise in the complete pharmaceutical profiling of molecules.
Polymorph, Salt And Hydrate Screening
API & Drug Product Development >> Preformulation & Material Science >> Polymorph & Crystal Screening
Polymorph screening, identification and evaluation, Comprehensive salt, hydrate or co-crystal screening studies